The United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against the capsid of enterovirus D68 (EV-D68)...
LONDON, Sept. 28, 2022 (GLOBE NEWSWIRE) -- KBio, a leading developer of new biological treatments derived from a plant-based production system, today announced the formation of a strategic collaboration with Leaf Expression Systems Ltd. (LES), the leading UK-based plant-made pharmaceuticals R&D company. Through this collaboration, KBio will explore how LES’ cutting-edge technologies can be applied to its existing plant-based platform to enhance current and future development and production of novel protein-based therapeutics for rare and infectious diseases.